Search research articles
Contact Us
Filters
Showing results (111-120 of 149) with videos related to
Page
of 15
Sort By:
Journal of Autoimmunity
|
September 25, 2023
Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469]
Dongdong Zhang, Andrew J Kinloch, Abhinav Srinath, et al.
Circulation Research
|
December 23, 2017
Infarct Fibroblasts Do Not Derive From Bone Marrow Lineages
Thomas Moore-Morris, Paola Cattaneo, Nuno Guimarães-Camboa, et al.
Translational Stroke Research
|
August 26, 2019
A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease
Lisa McKerracher, Robert Shenkar, Matthew Abbinanti, et al.
The Journal of Experimental Medicine
|
October 4, 2017
Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations
Miguel Alejandro Lopez-Ramirez, Gregory Fonseca, Hussein A Zeineddine, et al.
Angiogenesis
|
July 26, 2020
Novel Murine Models of Cerebral Cavernous Malformations
Matthew R Detter, Robert Shenkar, Christian R Benavides, et al.
The Journal of Clinical Investigation
|
December 10, 2020
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Wenqing Li, Robert Shenkar, Mathew R Detter, et al.
The Journal of Clinical Investigation
|
October 1, 2021
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Wenqing Li, Robert Shenkar, Mathew R Detter, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
April 18, 2016
B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models
Changbin Shi, Robert Shenkar, Hussein A Zeineddine, et al.
Circulation Research
|
May 4, 2018
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth
Romuald Girard, Hussein A Zeineddine, Janne Koskimäki, et al.
Stroke
|
November 24, 2016
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations
Robert Shenkar, Changbin Shi, Cecilia Austin, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 149) with videos related to
Sort By:
Page
of 15
Journal of Autoimmunity
|
September 25, 2023
Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469]
Dongdong Zhang, Andrew J Kinloch, Abhinav Srinath, et al.
Circulation Research
|
December 23, 2017
Infarct Fibroblasts Do Not Derive From Bone Marrow Lineages
Thomas Moore-Morris, Paola Cattaneo, Nuno Guimarães-Camboa, et al.
Translational Stroke Research
|
August 26, 2019
A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease
Lisa McKerracher, Robert Shenkar, Matthew Abbinanti, et al.
The Journal of Experimental Medicine
|
October 4, 2017
Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations
Miguel Alejandro Lopez-Ramirez, Gregory Fonseca, Hussein A Zeineddine, et al.
Angiogenesis
|
July 26, 2020
Novel Murine Models of Cerebral Cavernous Malformations
Matthew R Detter, Robert Shenkar, Christian R Benavides, et al.
The Journal of Clinical Investigation
|
December 10, 2020
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Wenqing Li, Robert Shenkar, Mathew R Detter, et al.
The Journal of Clinical Investigation
|
October 1, 2021
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Wenqing Li, Robert Shenkar, Mathew R Detter, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
April 18, 2016
B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models
Changbin Shi, Robert Shenkar, Hussein A Zeineddine, et al.
Circulation Research
|
May 4, 2018
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth
Romuald Girard, Hussein A Zeineddine, Janne Koskimäki, et al.
Stroke
|
November 24, 2016
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations
Robert Shenkar, Changbin Shi, Cecilia Austin, et al.
Page
of 15